Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification
Robert P. Hasserjian(Massachusetts General Hospital), Sa A. Wang(Beijing Institute of Technology), Lynne V. Abruzzo(The University of Texas MD Anderson Cancer Center), Armen Kasyan(The University of Texas MD Anderson Cancer Center), Rajyalakshmi Luthra, Christine Garcia(University of Pittsburgh), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), L. Jeffrey Medeiros(Delaware Division of Libraries), Zhuang Zuo(The University of Texas MD Anderson Cancer Center), Guilin Tang(The University of Texas MD Anderson Cancer Center)
Cited by 108
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k